Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 17 Stomach Neoplasms 8 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Rectal Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Recurrence 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Resectable NSCLC 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Meningeal Carcinomatosis 1 MSI-H 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Carboplatin 47 Etoposide 46 durvalumab 28 atezolizumab 28 Cisplatin 21 Topotecan 19 pembrolizumab 15 PM 01183 15 Nivolumab 12 Specimen Handling 11 anlotinib 9 Radiotherapy 9 Paclitaxel 9 Drug Therapy 9 Temozolomide 8 Magnetic Resonance Spectroscopy 8 AMG 757 8 Radiosurgery 7 Platinum 7 Irinotecan 7 toripalimab 6 olaparib 6 Biopsy 6 Ipilimumab 5 Injections 5 Docetaxel 5 Bevacizumab 5 trilaciclib 4 tremelimumab 4 tislelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × sintilimab × 1 year × Clear all

NCT07061535 2025-07-11

STAR-SCLC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡